Abstract
Therapies that are believed to target the underlying mechanisms of Alzheimers disease have now reached human clinical trials, with the number of agents in late stage development having increased dramatically in recent years. Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimers disease, and tau protein which, when hyperphosphorylated, results in the formation of neurofibrillary tangles of paired helical filaments, also believed to be involved in the pathogenesis of Alzheimers disease. In the review, the current status of Alzheimers Disease therapies under study is discussed, including the scientific basis for each strategy.
Keywords: Alzheimer's disease, clincal trials, drug development for Alzheimer's disease, mild cognitive impairment
Reviews on Recent Clinical Trials
Title: The Pulse of Drug Development for Alzheimers Disease
Volume: 5 Issue: 1
Author(s): Michael S. Rafii
Affiliation:
Keywords: Alzheimer's disease, clincal trials, drug development for Alzheimer's disease, mild cognitive impairment
Abstract: Therapies that are believed to target the underlying mechanisms of Alzheimers disease have now reached human clinical trials, with the number of agents in late stage development having increased dramatically in recent years. Primary targets include beta-amyloid, whose presence and accumulation in the brain is thought to contribute to the development of Alzheimers disease, and tau protein which, when hyperphosphorylated, results in the formation of neurofibrillary tangles of paired helical filaments, also believed to be involved in the pathogenesis of Alzheimers disease. In the review, the current status of Alzheimers Disease therapies under study is discussed, including the scientific basis for each strategy.
Export Options
About this article
Cite this article as:
Rafii S. Michael, The Pulse of Drug Development for Alzheimers Disease, Reviews on Recent Clinical Trials 2010; 5 (1) . https://dx.doi.org/10.2174/157488710790820490
DOI https://dx.doi.org/10.2174/157488710790820490 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mechanisms of HIV-1 Neurotropism
Current HIV Research Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Reverse Vaccinology: An Epitope Based Approach to Design Vaccines
Current Bioinformatics The Cytokine Network in HIV Infection
Current Molecular Medicine The Use of Lectins as Tools to Combat SARS-CoV-2
Current Pharmaceutical Design Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy
Current HIV Research Biological Activities of Artemisinin Derivatives Beyond Malaria
Current Topics in Medicinal Chemistry Clinical Assessment of Carotid Atherosclerosis Inflammation by Positron Emission Tomography
Current Molecular Medicine Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Current HIV Research Nanoparticle Enabled Drug Delivery Across the Blood Brain Barrier: in vivo and in vitro Models, Opportunities and Challenges
Current Pharmaceutical Biotechnology Current Status of Anti-HIV Agents
Current Medicinal Chemistry - Anti-Infective Agents Cytokine Network in Inflammatory Bowel Disease
Current Drug Targets - Inflammation & Allergy Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism Vaccine-Associated Neurological Adverse Events: A Case Report and Literature Review
Current Pharmaceutical Design Pathways by Which Aβ Facilitates Tau Pathology
Current Alzheimer Research Biology of Mesenchymal Stem Cells
Current Rheumatology Reviews Tactile Angle Discrimination Decreases due to Subjective Cognitive Decline in Alzheimer’s Disease
Current Alzheimer Research Gymnema sylvestre R. Br., an Indian Medicinal Herb: Traditional Uses, Chemical Composition, and Biological Activity
Current Pharmaceutical Biotechnology Hendra and Nipah Viruses: Pathogenesis and Therapeutics
Current Molecular Medicine Activation of Latent HIV-1 Expression by Protein Kinase C Agonists. A Novel Therapeutic Approach to Eradicate HIV-1 Reservoirs
Current Drug Targets